CRISPR

CRISPR1-alkal1

ID

ZDB-CRISPR-180813-1

Name

CRISPR1-alkal1

Previous Names

None

Target

alkal1 (1)

Sequence

5' - GGTCTGCTGTTGTCCGGCTT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
t613A	alkal1

Expression

Gene expression in Wild Types + CRISPR1-alkal1

No data available

Phenotype

Phenotype resulting from CRISPR1-alkal1

No data available

Phenotype of all Fish created by or utilizing CRISPR1-alkal1

Phenotype	Fish	Conditions	Figures
opercular flap iridophore decreased amount, abnormal	alkal1^t613A/t613A	standard conditions	Fig. 4 from Fadeev et al., 2018
opercular flap has fewer parts of type iridophore, abnormal	alkal1^t613A/t613A	standard conditions	Fig. 4 from Fadeev et al., 2018
opercular flap iridophore decreased amount, abnormal	alkal1^t613A/t613A; alkal2a^t614A/t614A	standard conditions	Fig. 4 from Fadeev et al., 2018
opercular flap has fewer parts of type iridophore, abnormal	alkal1^t613A/t613A; alkal2a^t614A/t614A	standard conditions	Fig. 4 from Fadeev et al., 2018
opercular flap iridophore decreased amount, abnormal	alkal1^t613A/t613A; alkal2b^t615B/t615B	standard conditions	Fig. 4 from Fadeev et al., 2018
opercular flap has fewer parts of type iridophore, abnormal	alkal1^t613A/t613A; alkal2b^t615B/t615B	standard conditions	Fig. 4 from Fadeev et al., 2018
eye has fewer parts of type iridophore, abnormal	alkal1^t613A/t613A; alkal2b^t615B/t615B	standard conditions	Fig. 4 from Fadeev et al., 2018
eye iridophore decreased amount, abnormal	alkal1^t613A/t613A; alkal2b^t615B/t615B	standard conditions	Fig. 4 from Fadeev et al., 2018
iridophore decreased amount, abnormal	alkal1^t613A/+; alkal2b^t615B/+; alkal2a^t614A/t614A	standard conditions	Fig. 4 from Fadeev et al., 2018
melanophore stripe morphology, abnormal	alkal1^t613A/+; alkal2b^t615B/+; alkal2a^t614A/t614A	standard conditions	Fig. 4 from Fadeev et al., 2018
melanophore stripe irregular spatial pattern, abnormal	alkal1^t613A/+; alkal2b^t615B/+; alkal2a^t614A/t614A	standard conditions	Fig. 4 from Fadeev et al., 2018
melanophore stripe irregular spatial pattern, abnormal	alkal1^t613A/t613A; alkal2b^t615B/+; alkal2a^t614A/t614A	standard conditions	Fig. 4 from Fadeev et al., 2018
iridophore decreased amount, abnormal	alkal1^t613A/t613A; alkal2b^t615B/+; alkal2a^t614A/t614A	standard conditions	Fig. 4 from Fadeev et al., 2018
melanophore stripe morphology, abnormal	alkal1^t613A/t613A; alkal2b^t615B/+; alkal2a^t614A/t614A	standard conditions	Fig. 4 from Fadeev et al., 2018
opercular flap has fewer parts of type iridophore, abnormal	alkal1^t613A/t613A; alkal2b^t615B/t615B; alkal2a^t614A/+	standard conditions	Fig. 4 from Fadeev et al., 2018
opercular flap iridophore decreased amount, abnormal	alkal1^t613A/t613A; alkal2b^t615B/t615B; alkal2a^t614A/+	standard conditions	Fig. 4 from Fadeev et al., 2018
eye iridophore decreased amount, abnormal	alkal1^t613A/t613A; alkal2b^t615B/t615B; alkal2a^t614A/+	standard conditions	Fig. 4 from Fadeev et al., 2018
eye has fewer parts of type iridophore, abnormal	alkal1^t613A/t613A; alkal2b^t615B/t615B; alkal2a^t614A/+	standard conditions	Fig. 4 from Fadeev et al., 2018
whole organism dead, abnormal	alkal1^t613A/t613A; alkal2b^t615B/t615B; alkal2a^t614A/t614A	standard conditions	Fig. 4 from Fadeev et al., 2018
whole organism lacks all parts of type iridophore, abnormal	alkal1^t613A/t613A; alkal2b^t615B/t615B; alkal2a^t614A/t614A	standard conditions	Fig. 4 from Fadeev et al., 2018

Citations